Sort
10,766 grants matching “checkpoint inhibitor”
Engineer A Chemogenetic Toolbox for Unraveling Complex Signaling Networks
$321,146Jie Zhou · University Of Chicago · R21 · FY2025 · EB
E2A/HEB TRANSCRIPTION FACTORS IN T CELL DEVELOPMENT
$321,081Yuan Zhuang · Duke University · R01 · FY2011 · GM
Administrative Core
$321,053Peter Karl Sorger · Harvard Medical School · U54 · FY2020 · CA
Control and coordination of the maternal-to-zygotic transition
$321,018Jan M Skotheim · Stanford University · R01 · FY2018 · HD
Targeted immunotherapy for relapsed/refractory Hodgkin lymphoma
$320,777Robert Wi Chen · Beckman Research Institute/City Of Hope · P50 · FY2021 · CA
Control and coordination of the maternal-to-zygotic transition
$320,706Jan M Skotheim · Stanford University · R01 · FY2017 · HD
Function and mechanism of REDD1/mTOR signaling in metabolism and tumorigenesis
$320,682Leif W Ellisen · Massachusetts General Hospital · R01 · FY2013 · CA
Function and mechanism of REDD1/mTOR signaling in metabolism and tumorigenesis
$320,682Leif W Ellisen · Massachusetts General Hospital · R01 · FY2016 · CA
Function and mechanism of REDD1/mTOR signaling in metabolism and tumorigenesis
$320,682Leif W Ellisen · Massachusetts General Hospital · R01 · FY2015 · CA
Function and mechanism of REDD1/mTOR signaling in metabolism and tumorigenesis
$320,682Leif W Ellisen · Massachusetts General Hospital · R01 · FY2017 · CA
Chemical Genetic Analysis of the Human Cell Cycle
$320,678Robert P Fisher · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · GM
Chemical Genetic Analysis of the Human Cell Cycle
$320,678Robert P Fisher · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · GM
Chemical Genetic Analysis of the Human Cell Cycle
$320,678Robert P Fisher · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · GM
Genomic Instability at DNA Nicks
$320,588Nancy Maizels · University Of Washington · R01 · FY2017 · CA
ATM as target for malignant glioma radiosensitization.
$320,491Kristoffer Valerie · Virginia Commonwealth University · R01 · FY2012 · NS
ATM as target for malignant glioma radiosensitization.
$320,491Kristoffer Valerie · Virginia Commonwealth University · R01 · FY2011 · NS
Project 3: KDM5 Histone Demethylases in Melanoma Growth and Tumor Immunity
$320,464Qin Yan · Yale University · P50 · FY2020 · CA
Project 2- Liquid Biopsies for Melanoma that Metastasizes to Inaccessible Sites
$320,464David A. Hafler · Yale University · P50 · FY2020 · CA
Harnessing the therapeutic potential of histotripsy focused ultrasound-induced immunogenic cancer cell death
$320,452Clifford Cho · Van Andel Research Institute · R01 · FY2024 · CA
The MRAD9 Radioresistance Gene
$320,390Howard B Lieberman · Columbia University Health Sciences · R01 · FY2006 · GM
Radiation-Induced Crosstalk of Immune and Glioma Stem Cells
$320,209Ichiro Nakano · University Of Alabama At Birmingham · R01 · FY2019 · NS
Expression of Class I Specific Receptors in NK Cells
$320,208David H Raulet · University Of California Berkeley · R01 · FY2008 · AI
Investigating the PD-L1:NLRP3 signaling axis as a tumor intrinsic mechanism of adaptive resistance to anti-PD-1 antibody immunotherapy
$320,179Brent Allen Hanks · Duke University · R37 · FY2022 · CA
Control and coordination of the maternal-to-zygotic transition
$320,114Jan M Skotheim · Stanford University · R01 · FY2016 · HD
Project 1: Overcoming Tumor-Induced Immune Suppression to Improve Responses to Immunotherapy
$319,955David G Denardo · Washington University · P50 · FY2019 · CA